| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 07/22/1999 | WO1999036429A2 Nucleobase oligomers |
| 07/22/1999 | WO1999036383A1 Substances capable of inducing apoptosis |
| 07/22/1999 | WO1999036073A1 Method of inhibiting interleukin-12 signaling |
| 07/22/1999 | CA2318393A1 A substance having an apoptosis-inducing ability |
| 07/22/1999 | CA2317677A1 Nucleobase oligomers |
| 07/21/1999 | CN1223654A N-[4-(heteroarylmethyl) phenyl]-heteroarylamines |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/20/1999 | US5925756 Cyclopropane derivatives and method of preparing the same |
| 07/20/1999 | US5925643 Treating human immunodeficiency virus infections |
| 07/15/1999 | WO1999035148A1 Compounds for increased bioavailability |
| 07/15/1999 | WO1999035147A1 Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| 07/15/1999 | CA2315736A1 Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus |
| 07/14/1999 | CN1044089C Medicine composition with enantiomerically pure beta-D-dioxolane nucleosides as active component |
| 07/13/1999 | US5922868 1-(4,4-ethylenedioxy-3-methylpentyl)-3-methyl-7-propylxanthine |
| 07/13/1999 | US5922867 Method and compositions for the synthesis of dioxolane nucleosides with β configuration |
| 07/13/1999 | US5922710 Iminooxybenzylcrotonate esters, their preparation and their use |
| 07/13/1999 | US5922694 Optically-active isomers of dideoxycarbocyclic nucleosides |
| 07/13/1999 | CA2033044C 6-substituted purine carbocyclic nucleosides |
| 07/13/1999 | CA1340645C Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus |
| 07/08/1999 | WO1999034018A1 Methods of using chemical libraries to search for new kinase inhibitors |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927167A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 07/07/1999 | EP0927166A1 Amides as npy5 receptor antagonists |
| 07/06/1999 | US5919941 Intermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acid |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/01/1999 | WO1999032507A2 Intermediates and process for the synthesis of 17-unsubstituted 16.beta.-aryloxy 4-azasteroids |
| 07/01/1999 | WO1999032490A1 Prodrugs of lobucavir and methods of use |
| 07/01/1999 | WO1999032477A1 Ortho-anthranilamide derivatives as anti-coagulants |
| 07/01/1999 | WO1999032122A1 Type 2 helper t cell-selective immune response suppressors |
| 07/01/1999 | CA2315070A1 Ortho-anthranilamide derivatives as anti-coagulants |
| 06/30/1999 | EP0926131A2 Process for the preparation of aminoalcohol derivatives and their further transformation zu (1R,4S)-4-((2-amino-6-chlor-5-formamido-4-pyrimidinyl)-amino)-2-cyclopenten-1-methanol |
| 06/30/1999 | CN1221419A Amide derivatives |
| 06/29/1999 | US5917042 Process for the preparation of 2,5-diamino-4,6-dichloropyrimidine |
| 06/29/1999 | US5917041 Amination and cyclization reaction with amine to make2-aminopurine nucleosides |
| 06/29/1999 | US5917040 2-fluoro-9-trimethylsilyladenine |
| 06/29/1999 | US5916894 Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
| 06/29/1999 | US5916893 Treatment of a latent infection of herpes virus |
| 06/29/1999 | US5916892 Administering to the patient suffering of allograft rejection, autoimmune disease, insulin-dependent diabetic mellitus, multiple sclerosis, rheumatoid arthritis, myesthenia gravis, lupus erythematosus and septic shock syndrome |
| 06/24/1999 | WO1999031105A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines |
| 06/24/1999 | WO1999031103A1 Preparation of 3-substituted adenines |
| 06/24/1999 | WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | WO1999031101A1 Adenosine receptor antagonists with improved bioactivity |
| 06/24/1999 | WO1999015509A3 Cyclohexyl and heterocyclyl nucleoside derivatives, method for producing these derivatives, and the use of the derivatives and their oligomers or conjugates in pairing and/or testing systems |
| 06/24/1999 | CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | CA2313004A1 3-substituted adenines via2-thioxanthines |
| 06/22/1999 | US5914233 Screening assay for the identification of agents which alter expression of PTH-rP |
| 06/22/1999 | CA2147893C Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis .beta. virus activity |
| 06/17/1999 | WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis |
| 06/17/1999 | WO1999029660A1 Adamantane derivatives |
| 06/17/1999 | CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis |
| 06/17/1999 | CA2312889A1 Adamantane derivatives |
| 06/16/1999 | EP0757684B1 Process for the diastereoselective synthesis of nucleoside analogues |
| 06/16/1999 | CN1043640C Process for preparing oxazolyl derivatives |
| 06/16/1999 | CN1043610C Novel treatment agent |
| 06/15/1999 | US5912252 Compounds as enzyme inhibitors of purine nucleoside phosphorylase |
| 06/10/1999 | WO1999028321A1 Novel heterocyclic compounds |
| 06/10/1999 | WO1999028320A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof |
| 06/09/1999 | EP0921121A1 Intermediates to therapeutic nucleosides |
| 06/09/1999 | EP0921114A1 Intermediates to therapeutic nucleosides |
| 06/09/1999 | EP0920430A1 Purine derivatives and their use as anti-coagulants |
| 06/09/1999 | CN1218795A Process for preparation of aminoalcohol derivatives and their further conversion to (1R,4S)-4-((2-amino-6-chloro-5-formamido-4-pyrimidinyl) amino)-2-cyclopentenyl-1-methanol |
| 06/08/1999 | US5910589 Pharmaceuticals preparation of 2-amino-6-chloropurine with TEMAC |
| 06/08/1999 | CA1340589C Therepeutic nucleosides |
| 06/03/1999 | WO1999026933A1 Substituted amidinoaryl derivatives and their use as anticoagulants |
| 06/02/1999 | EP0918852A1 Probe for analysis of nucleic acids |
| 05/27/1999 | CA2591571A1 Process for the preparation of aminoalcohol derivatives and their further conversion to (1s,4r)- or (1r,4s)-1-amino-4-(hydroxymethyl)-2-cyclopentene |
| 05/26/1999 | CN1043473C 8-substituted xanthines as selective adenosine receptor agents |
| 05/25/1999 | CA2062299C Cyclopropane derivatives |
| 05/20/1999 | WO1999024432A1 Purine derivatives and medicine containing the same as the active ingredient |
| 05/20/1999 | WO1999024431A1 Process for preparing a chiral nucleoside analogue |
| 05/20/1999 | WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules |
| 05/19/1999 | EP0916674A1 Purine derivatives having cyclopropane ring |
| 05/19/1999 | EP0916673A1 6-Amino purine derivatives having PDE-IV inhibition activity |
| 05/19/1999 | EP0916672A1 6-Amino purine derivatives having PDE-IV inhibition activity and intermediates |
| 05/19/1999 | EP0915874A2 Process of preparation of valacyclovir and relevant intermediates |
| 05/19/1999 | EP0772440A4 Carbon monoxide dependent guanylyl cyclase modifiers |
| 05/18/1999 | US5905085 Antigens and immunosuppressants |
| 05/18/1999 | US5904938 Anticoagulants using nitric oxide by breathing |
| 05/18/1999 | CA1340543C Pharmaceutically active compounds |
| 05/14/1999 | WO1998051697A3 Method for producing polymers having nucleo-bases as side-groups |
| 05/14/1999 | WO1997035539A3 Arylamino fused pyridines and pyrimidines |
| 05/12/1999 | EP0915093A1 Amide derivatives |
| 05/12/1999 | EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 05/12/1999 | EP0654037B1 Antiretroviral enantiomeric nucleotide analogs |
| 05/12/1999 | CN1043348C Asymmetrically substituted xanthines its producting process and its application as pharmaceutical composition |
| 05/12/1999 | CA2251481A1 Purine derivatives having cyclopropane ring |
| 05/06/1999 | WO1999021861A1 Process for preparing a chiral nucleoside analogue |
| 05/06/1999 | EP0912575A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 05/06/1999 | EP0912553A1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/06/1999 | EP0912542A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex |
| 05/06/1999 | EP0912520A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 05/06/1999 | EP0570519B1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 05/04/1999 | CA2078129C O6-benzylated guanine, guanosine and 2'- deoxyguanosine compounds possessing o6-alkylguanine-dna alkyltransferase depleting activity |
| 04/29/1999 | WO1999020625A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | WO1999020280A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | CA2306985A1 Novel use of compounds for anti-pruritic activity |
| 04/29/1999 | CA2306980A1 Novel polymorphic forms of cipamfylline |
| 04/28/1999 | CN1215051A 'Alpha' substituted benzyl propionate derivant and medicine containing same |
| 04/22/1999 | WO1999019327A1 Process for the synthesis of chloropurine intermediates |